Author: Alex Lathbridge

The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

Scientists working on the TRACERx project have mapped how the immune systems responds to lung tumours over time

We caught up with people living with cancer across the country, to find out how isolation due to the pandemic has been affecting them and their families.

Dr Alan Parker’s team in Cardiff are engineering viruses to help develop a COVID-19 vaccine.

Scientists are using a 3D printed brain to study how glioblastoma respond to treatment.

Scientists are developing a new drug that combines chemotherapy and light therapy.